MARKET

GILD

GILD

Gilead Sciences Inc
NASDAQ
90.19
+0.43
+0.48%
After Hours: 90.26 +0.07 +0.08% 19:59 11/22 EST
OPEN
89.81
PREV CLOSE
89.76
HIGH
90.49
LOW
89.27
VOLUME
4.55M
TURNOVER
--
52 WEEK HIGH
98.90
52 WEEK LOW
60.75
MARKET CAP
112.40B
P/E (TTM)
1073.69
1D
5D
1M
3M
1Y
5Y
1D
Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
NASDAQ · 10h ago
3 ‘Buy’ stocks and 2 ‘Hold’ stocks according to Oppenheimer
Seeking Alpha · 13h ago
Gilead Sciences Is Maintained at Neutral by UBS
Dow Jones · 1d ago
Gilead Sciences Price Target Raised to $96.00/Share From $70.00 by UBS
Dow Jones · 1d ago
UBS Maintains Neutral on Gilead Sciences, Raises Price Target to $96
Benzinga · 1d ago
Optimism over global healthcare sector rises: Jefferies
Seeking Alpha · 1d ago
Gilead price target raised to $96 from $70 at UBS
TipRanks · 1d ago
HQH: Declines Bring Potential Opportunity
Seeking Alpha · 1d ago
More
About GILD
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries.

Webull offers Gilead Sciences, Inc. stock information, including NASDAQ: GILD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GILD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GILD stock methods without spending real money on the virtual paper trading platform.